HR Execs on the Move


 
ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.acell.com
  • 6640 Eli Whitney Drive
    Columbia, MD USA 21046
  • Phone: 800.826.2926

Executives

Name Title Contact Details

Similar Companies

Metrix Co

Metrix Co is a Dubuque, IA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Brown and Toland Physicians Services Organization

Brown & Toland Physicians Services Organization is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Surgical Technologies

Surgical Technologies is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medela

Through advancing research, observing natural behavior, and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients, and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela provides the leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education.

HeartFlow

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.